1998
DOI: 10.1210/endo.139.3.5778
|View full text |Cite
|
Sign up to set email alerts
|

Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells1

Abstract: The mechanisms by which glucocorticosteroids promote osteoclastogenesis in vitro are uncertain. As macrophage colony-stimulating factor (MCSF) is critical for osteoclastogenesis, we hypothesized that glucocorticosteroids might regulate membrane-bound MCSF (mMCSF) and soluble MCSF (sMCSF) production by stromal cells or osteoblasts. ST2 cells or murine calvarial osteoblasts (MOBs) were treated with dexamethasone (Dex; 100 nM) and/or 1,25-dihydroxyvitamin D [1,25(OH)2D; 10 nM] for 3 days. Control values for mMCSF… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

1999
1999
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 87 publications
(8 citation statements)
references
References 37 publications
0
8
0
Order By: Relevance
“…In our culture system, however, the stimulation occurred even in the absence of the osteoclast-supporting cells such as osteoblasts. In addition, Dex has been demonstrated in cultures of human and murine osteoblasts to increase the expression of RANKL and M-CSF, which are essential for osteoclastogenesis, and to decrease the production of osteoprotegerin, which is a decoy receptor of RANK that interferes with RANKL/RANK signalings (34,35,50,51). This indirect action of GC via osteoblastic cells is one of the mechanisms for GCinduced osteoclastogenesis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In our culture system, however, the stimulation occurred even in the absence of the osteoclast-supporting cells such as osteoblasts. In addition, Dex has been demonstrated in cultures of human and murine osteoblasts to increase the expression of RANKL and M-CSF, which are essential for osteoclastogenesis, and to decrease the production of osteoprotegerin, which is a decoy receptor of RANK that interferes with RANKL/RANK signalings (34,35,50,51). This indirect action of GC via osteoblastic cells is one of the mechanisms for GCinduced osteoclastogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, many in vitro studies have indicated the direct action of GCs on osteoblasts (31)(32)(33). Recent studies (34,35) show that GC acts directly on osteoblasts to up-regulate the expression of RANKL and M-CSF and that the steroid oppositely down-regulates osteoprotegerin, a decoy receptor of RANKL that prevents the transmission of the RANKL signal into cells of the osteoclast lineage. This regulation is likely to be a mechanism for induction of bone resorption by GCs.…”
mentioning
confidence: 99%
“…Glucocorticoids including cortisol inhibit calcium absorption, an increase of urinary calcium excretion (Canalis and Delany, 2002), inhibit bone formation as well as increase bone resorption, which lead to osteoporosis after continued exposure to elevated cortisol (Hahn et al, 1979;Canalis, 1996;Dalle Carbonare et al, 2001). Cortisol increases the expression of the crucial osteoclastogenesis factor M-CSF (Rubin et al, 1998) while decreasing the production of the anti-resorptive RANK-L decoy receptor osteoprotegrin (downregulated in MONA patients; Figure 3C; Hofbauer et al, 1999), therefore promoting bone resorption and osteoclastogenesis while disrupting the coupled osteoblast-osteoclast interaction (Canalis and Delany, 2002). Cortisol can decrease osteoblasts replication and slow their differentiation into mature osteoblasts (Pereira et al, 2001;Canalis and Delany, 2002).…”
Section: Figure 4 | (A)mentioning
confidence: 99%
“…The cellsurface form of CSF-1 is expressed in bone marrow stromal cells (45), osteoblasts (46,47) and cells of endometrial glands (48). Furthermore, the expression of membrane-anchored CSF-1 in osteoblast-like cells can be regulated by parathyroid hormone, tumor necrosis factor, and dexamethone treatment (49,50). CSF-1R is expressed in monocytes, macrophages, osteoclasts, and their precursors (13,14).…”
Section: Csf-1mentioning
confidence: 99%